ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?
TipRanks (Fri, 26-Apr 12:09 PM ET)
Options Exercise: Rainer Blair At Danaher Realizes $7.05M
Benzinga (Fri, 26-Apr 11:01 AM ET)
Buy Rating on Danaher: Strong Biotech Performance and Growth Potential Despite Market Challenges
TipRanks (Fri, 26-Apr 2:06 AM ET)
TipRanks (Wed, 24-Apr 7:20 AM ET)
RBC Capital Sticks to Its Buy Rating for Danaher (DHR)
TipRanks (Wed, 24-Apr 6:46 AM ET)
TipRanks (Wed, 24-Apr 4:50 AM ET)
TipRanks (Tue, 23-Apr 9:41 AM ET)
Biggest stock movers today: SPOT, GM, DHR, IBRX, NVS, and more
Seeking Alpha News (Tue, 23-Apr 9:36 AM ET)
Biggest stock movers today: DHR, IBRX, NVS, and more
Seeking Alpha News (Tue, 23-Apr 8:36 AM ET)
Biggest stock movers today: GM, DHR, IBRX, NVS, and more
Seeking Alpha News (Tue, 23-Apr 8:36 AM ET)
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Danaher trades on the NYSE stock market under the symbol DHR.
As of April 26, 2024, DHR stock price climbed to $246.58 with 2,592,911 million shares trading.
DHR has a beta of 1.15, meaning it tends to be more sensitive to market movements. DHR has a correlation of 0.34 to the broad based SPY ETF.
DHR has a market cap of $182.60 billion. This is considered a Large Cap stock.
Last quarter Danaher reported $6 billion in Revenue and $1.92 earnings per share. This beat revenue expectation by $176 million and exceeded earnings estimates by $.21.
In the last 3 years, DHR stock traded as high as $333.96 and as low as $182.09.
The top ETF exchange traded funds that DHR belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
DHR has outperformed the market in the last year with a price return of +31.1% while the SPY ETF gained +26.8%. DHR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +8.6% and +1.1%, respectively, while the SPY returned +4.5% and -1.9%, respectively.
DHR support price is $242.17 and resistance is $249.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DHR stock will trade within this expected range on the day.